Further studies on the mechanism of suppression of human lymphocyte transformation by human alpha fetoprotein.
D003208:Concanavalin A / Q000494:pharmacology; D004306:Dose-Response Relationship, Immunologic; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D007165:Immunosuppression Therapy; D007213:Indomethacin / Q000494:pharmacology; D007525:Isoelectric Focusing; D007700:Kinetics; D008213:Lymphocyte Activation; D010504:Periodic Acid / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis; D011458:Prostaglandins E / Q000494:pharmacology; D011975:Receptors, Mitogen / Q000276:immunology; D000509:alpha-Fetoproteins / Q000494:pharmacology*
D011453:Prostaglandins; D011458:Prostaglandins E; D011975:Receptors, Mitogen; D000509:alpha-Fetoproteins; D010504:Periodic Acid; D003208:Concanavalin A; D007213:Indomethacin